Other studies have shown that Wnt inhibitory factor-1 (WIF1) is down-regulated in prostate cancer [172], and induced overexpression of WIF1 reverses EMT in prostate cancer cell lines and decreases their invasive capacity in vitro and in vivo [173]. This evidence concerns the gene WIF1 and prostate cancer.